Brain training by feedback: a new angle on depression

NCT ID NCT07815457

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers at Pontificia Universidad Catolica de Chile ran a small feasibility study to see whether women aged 18 to 35 with mild-to-moderate depressive symptoms could use real-time EEG neurofeedback to shift their brain activity toward a target pattern. Participants were randomly split into two groups: one received visual feedback tied to their brain signals plus small cash rewards, and the other received sham feedback with matching rewards. Everyone attended five sessions over about three weeks. The main question was whether the brain-signal classifier performed better than chance, with symptom changes and tolerability tracked as secondary measures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EEG neurofeedback guided by a pretrained classifier, with visual feedback and small monetary rewards
What this could lead to
If it works, this could point toward a low-cost, non-drug way to help people with mild-to-moderate depressive symptoms train their own brain activity.
What could go wrong
The study is tiny, with 20 participants, and it only checks whether the approach is feasible. It cannot show whether symptoms improve, and any benefit may come from placebo or the reward money rather than the brain training.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Jan 2019

Finished

Jan 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Self-identification as a woman. * Female sex assigned at birth, reported during the intake interview * Self-reported right-handedness * Age 18-35 years * Beck Depression Inventory-II score of 14-29 * Hamilton Depression Rating Scale score below 24 * Score below 2 on the suicide-related item of both the Beck Depression * Inventory-II and Hamilton Depression Rating Scale Exclusion Criteria: * Current psychotherapy * Self-reported history of bipolar disorder or schizophrenia * Prior suicide attempt * Self-reported history of post-traumatic stress disorder, obsessive-compulsive disorder, substance use disorder, or anorexia nervosa * Neurological disorder, including dementia, brain tumor, or epilepsy * Intellectual disability * Regular or intermittent use of benzodiazepines, anticonvulsants, or psychostimulants * Use of another psychotropic medication unless the medication and dose had remained unchanged for at least 3 months before enrollment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depressive sympotoms are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Laboratory for Brain-Machine Interfaces and Neuromodulation, Pontificia Universidad Católica de Chile

    Santiago, RM, 8320000, Chile

More trials for these conditions

Other studies related to the condition(s) this trial covers.